Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angela Vidal

Showing results (101-110 of 123) with videos related to

Pageof 13
Sort By:
Network Neuroscience (Cambridge, Mass.)|December 30, 2024
Conservation of structural brain connectivity in people with multiple sclerosisGerard Martí-Juan, Jaume Sastre-Garriga, Angela Vidal-Jordana, et al.
Neurology|March 6, 2024
Trans-Synaptic Degeneration in the Visual Pathway in Patients With Myelin Oligodendrocyte Glycoprotein Antibody-Associated DiseaseLuca Bollo, Georgina Arrambide, Alvaro Cobo-Calvo, et al.
Neurology|August 14, 2016
Neurofilament light chain level is a weak risk factor for the development of MSGeorgina Arrambide, Carmen Espejo, Herena Eixarch, et al.
Multiple Sclerosis and Related Disorders|November 30, 2025
"Effectiveness and associated factors of response to Fampridine in multiple sclerosis: A prospective observational study from an expert center"Elisa Martinez-Campos, Miguel Angel Robles, Rosalia Horno, et al.
Annals of Neurology|September 14, 2023
Myelin Oligodendrocyte Glycoprotein Antibodies in Adults with a First Demyelinating Event Suggestive of Multiple SclerosisJavier Villacieros-Álvarez, Carmen Espejo, Georgina Arrambide, et al.
Neurology|July 19, 2023
Association of Very Early Treatment Initiation With the Risk of Long-term Disability in Patients With a First Demyelinating EventAlvaro Cobo-Calvo, Carmen Tur, Susana Otero-Romero, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 30, 2025
Radiologically isolated syndrome: How could we accurately diagnose a subclinical period of multiple sclerosis?Andreu Vilaseca, Angela Vidal-Jordana, Sofia Sceppacuercia, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|September 17, 2019
Retinal inner nuclear layer volume reflects inflammatory disease activity in multiple sclerosis; a longitudinal OCT studyLisanne J Balk, Danko Coric, Benjamin Knier, et al.
Neurology|January 2, 2024
Adding the Optic Nerve in Multiple Sclerosis Diagnostic Criteria: A Longitudinal, Prospective, Multicenter StudyAngela Vidal-Jordana, Alex Rovira, Willem Calderon, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 29, 2024
Prediction of disease activity and treatment failure in relapsing-remitting MS patients initiating daily oral DMTsAgustin Pappolla, Cristina Auger, Augusto Sao-Aviles, et al.
Pageof 13

Showing results (101-110 of 123) with videos related to

Sort By:
Pageof 13
Network Neuroscience (Cambridge, Mass.)|December 30, 2024
Conservation of structural brain connectivity in people with multiple sclerosisGerard Martí-Juan, Jaume Sastre-Garriga, Angela Vidal-Jordana, et al.
Neurology|March 6, 2024
Trans-Synaptic Degeneration in the Visual Pathway in Patients With Myelin Oligodendrocyte Glycoprotein Antibody-Associated DiseaseLuca Bollo, Georgina Arrambide, Alvaro Cobo-Calvo, et al.
Neurology|August 14, 2016
Neurofilament light chain level is a weak risk factor for the development of MSGeorgina Arrambide, Carmen Espejo, Herena Eixarch, et al.
Multiple Sclerosis and Related Disorders|November 30, 2025
"Effectiveness and associated factors of response to Fampridine in multiple sclerosis: A prospective observational study from an expert center"Elisa Martinez-Campos, Miguel Angel Robles, Rosalia Horno, et al.
Annals of Neurology|September 14, 2023
Myelin Oligodendrocyte Glycoprotein Antibodies in Adults with a First Demyelinating Event Suggestive of Multiple SclerosisJavier Villacieros-Álvarez, Carmen Espejo, Georgina Arrambide, et al.
Neurology|July 19, 2023
Association of Very Early Treatment Initiation With the Risk of Long-term Disability in Patients With a First Demyelinating EventAlvaro Cobo-Calvo, Carmen Tur, Susana Otero-Romero, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 30, 2025
Radiologically isolated syndrome: How could we accurately diagnose a subclinical period of multiple sclerosis?Andreu Vilaseca, Angela Vidal-Jordana, Sofia Sceppacuercia, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|September 17, 2019
Retinal inner nuclear layer volume reflects inflammatory disease activity in multiple sclerosis; a longitudinal OCT studyLisanne J Balk, Danko Coric, Benjamin Knier, et al.
Neurology|January 2, 2024
Adding the Optic Nerve in Multiple Sclerosis Diagnostic Criteria: A Longitudinal, Prospective, Multicenter StudyAngela Vidal-Jordana, Alex Rovira, Willem Calderon, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 29, 2024
Prediction of disease activity and treatment failure in relapsing-remitting MS patients initiating daily oral DMTsAgustin Pappolla, Cristina Auger, Augusto Sao-Aviles, et al.
Pageof 13